Publication | Open Access
Oral Etoposide for Platinum-Resistant and Recurrent Epithelial Ovarian Cancer: a Study by the Anatolian Society of Medical Oncology
29
Citations
13
References
2012
Year
Chronic low-dose oral etoposide treatment is generally effective and well-tolerated in platinum-resistant ovarian cancer patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1